Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLW vs MRNA✓SelectedUSD · MRNAGLW vs MRNA performance historyLatest closeAs of-2.02%11/19
Stock and ETF performance explorer

GLW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+30.7%
MRNA return
+698.9%
Excess return
-668.2%
Maximum drawdown
-59.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.0%+1.3%-3.3%-2.0%
7D-11.1%-13.8%+2.7%-11.1%
30D-19.7%-17.7%-2.0%-19.6%
3M-30.2%+14.3%-44.5%-29.9%
6M-39.4%+336.0%-375.4%-41.1%
YTD+22.0%+575.9%-554.0%+10.2%
1Y+30.7%+724.4%-693.6%+7.8%
All+30.7%+698.9%-668.2%+7.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling